Aglaia chittagonga
Aglaia chittagonga · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Aglaia chittagonga is a significant botanical species known for its diverse pharmacological potential. Researchers frequently investigate this plant by utilizing various crude extracts to identify its bioactive components. These preparations serve as a primary foundation for exploring the plant's inherent medicinal properties. Through the analysis of these raw substances, scientists aim to uncover specific chemical constituents responsible for therapeutic effects. Consequently, studying these crude extracts remains essential for advancing our understanding of this plant's biological significance.
- Synonyms
- Amoora Chittagonga · Aphanamixis Chittagonga
- Common names
- Not available
- Family
- Meliaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Aglaia chittagonga is a unique botanical species known by several different regional identifiers. In certain linguistic contexts, it is referred to by the common name コウトウグミトベラ. It is also recognized by the name 蘭嶼樹蘭, which highlights its specific cultural or geographic associations. These diverse names reflect the plant's presence across various different regions and traditions. Understanding these common names helps enthusiasts and researchers identify the species more easily in different parts of the world.
Sources: Catalogue of Life (COL)
Synonyms
Aglaia chittagonga is a botanical species that has undergone various taxonomic reclassifications over time. Within scientific literature, this plant is frequently identified by its recognized synonyms. For instance, it is known in some records as Amoora chittagonga. Additionally, the species has been referred to as Aphanamixis chittagonga in different botanical contexts. Understanding these synonymous relationships is essential for accurate identification and research.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Aglaia chittagonga is a distinct botanical species belonging to the vast kingdom Plantae. Within this expansive biological realm, it is specifically classified under the class Equisetopsida. The plant further falls into the order Sapindales, showcasing its unique evolutionary lineage. As a member of the Meliaceae family, it shares structural characteristics with many other woody plants. Finally, its specific identity is defined by its placement within the genus Aglaia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Sapindales |
| Family | Meliaceae |
| Genus | Aglaia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Aglaia chittagonga is a notable species with a widespread presence throughout the tropical regions of Asia. Its distribution spans a significant portion of the Indian Subcontinent, including specific habitats in Assam, Bangladesh, and the East Himalaya. Beyond the subcontinent, the plant extends its reach into the Indo-China region. Specifically, it can be found growing in the natural landscapes of both Myanmar and Thailand. This broad geographic range highlights the plant's ability to thrive across diverse tropical ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Aglaia chittagonga is a self-supporting plant that typically exhibits a tree-like growth form. This species is characterized by its relatively modest stature, reaching a maximum height of only 5 meters. Its structural integrity allows it to stand firmly within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Aglaia chittagonga, also referred to as Amoora chittagonga, demonstrates significant therapeutic potential through its cytotoxic effects on various cell lines. The plant extract effectively treats the pancreatic adenocarcinoma cell line Panc-1 with specific IC50 values. Additionally, it shows efficacy in treating the Mia-Paca2 and Capan-1 pancreatic cancer cell lines. While targeting these cancer cells, the extract maintains low cytotoxicity when treating fibroblast cells. These combined interactions highlight the plant's targeted ability to combat pancreatic cancer cells while sparing healthy fibroblast cells.
Preparations
Aglaia chittagonga is prepared as crude extracts to investigate its therapeutic potential against pancreatic cancer cells. These specific extracts were included in a study of 56 medicinal plant extracts from Bangladesh to screen for cytotoxicity. Through the use of a label-free biosensor assay, the extracts were tested against the Panc-1 adenocarcinoma cell line. The research further evaluated these preparations using MTT proliferation assays on Mia-Paca2 and Capan-1 cell lines. This methodology allowed researchers to assess how the crude extracts interact with various cancer and fibroblast cell lines.